ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study

You may be eligible if

• Subjects who meet all of the following criteria may be given consideration for inclusion in this clinical investigation.
• Subjects who were enrolled, randomized and treated for paroxysmal atrial fibrillation, classified as Modified Intention-to-Treat subjects, and completed the 12-Month Follow-Up in the FARAPULSE ADVENT Trial (CIP CS0934; NCT04612244).
• Subjects or legally authorized representatives who are willing and capable of providing informed consent.
• Subjects who are willing to comply with the protocol requirements.